Table 3.
Measure | Group | Preoperative measure | 6 months | 12 months | P; repeated measures ANOVA | P; preoperative versus 6 m | P; preoperative versus 12 m | P; 6 m versus 12 m |
---|---|---|---|---|---|---|---|---|
UDVA (logMAR) |
G1 | 0.92 ± 0.33 | 0.19 ± 0.9 | 0.18 ± 0.06 | <0.001 | <0.001 | <0.001 | 0.66 |
G2 | 0.95 ± 0.31 | 0.14 ± 0.11 | 0.13 ± 0.08 | <0.001 | <0.001 | <0.001 | 0.45 | |
P ∗ | 0.35 | 0.08 | 0.07 | — | — | — | — | |
| ||||||||
CDVA (logMAR) |
G1 | 0.32 ± 0.25 | 0.14 ± 0.07 | 0.13 ± 0.08 | <0.001 | <0.001 | <0.001 | 0.86 |
G2 | 0.29 ± 0.22 | 0.09 ± 0.06 | 0.09 ± 0.05 | <0.001 | <0.001 | <0.001 | 0.91 | |
P ∗ | 0.41 | 0.13 | 0.06 | — | — | — | — | |
| ||||||||
Refractive sphere (D) | G1 | −2.2 ± 1.82 | −0.55 ± 0.82 | −0.53 ± 0.79 | <0.001 | <0.001 | <0.001 | 0.93 |
G2 | −1.8 ± 1.56 | −0.46 ± 0.66 | −0.42 ± 0.63 | <0.001 | <0.001 | <0.001 | 0.12 | |
P ∗ | 0.61 | 0.42 | 0.33 | — | — | — | — | |
| ||||||||
Refractive cylinder (D) | G1 | −2.9 ± 1.6 | −1.2 ± 0.79 | −1.2 ± 0.76 | <0.001 | <0.001 | <0.001 | 0.98 |
G2 | −2.7 ± 1.4 | −0.9 ± 0.66 | −0.9 ± 0.65 | <0.001 | <0.001 | <0.001 | 0.87 | |
P ∗ | 0.53 | 0.42 | 0.37 | — | — | — | — | |
| ||||||||
MRSE (D) | G1 | −3.7 ± 2.4 | −1.4 ± 0.72 | −1.3 ± 0.79 | <0.001 | <0.001 | <0.001 | 0.67 |
G2 | −3.8 ± 2.6 | −1.1 ± 0.71 | −1.00 ± 0.68 | <0.001 | <0.001 | <0.001 | 0.88 | |
P ∗ | 0.77 | 0.46 | 0.34 | — | — | — | — |
P ∗: unpaired t-test for comparison between the 2 groups.
Significant P values are bolded.
UDVA: uncorrected distant visual acuity.
CDVA: corrected distant visual acuity.
K max: maximum keratometry.
MRSE: mean refractive spherical equivalent.
D: diopter.